Loading...
Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
Triple negative breast cancers (TNBCs) are characterized by worse prognosis, higher propensity to earlier metastases, and shorter survival after recurrence compared with other breast cancer subtypes. Anthracycline- and taxane-based chemotherapy is still the mainstay of treatment in early stages, alt...
Saved in:
Published in: | Cancers (Basel) |
---|---|
Main Authors: | , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
MDPI
2020
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225917/ https://ncbi.nlm.nih.gov/pubmed/32235297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040819 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|